Sarepta Therapeutics, Inc. (SRPT)

USD 120.25

(-4.38%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 3.26 Billion 3.12 Billion 3.14 Billion 2.98 Billion 1.82 Billion 1.64 Billion
Total Current Assets 2.57 Billion 2.55 Billion 2.6 Billion 2.48 Billion 1.46 Billion 1.42 Billion
Cash And Short Term Investments 1.67 Billion 1.98 Billion 2.11 Billion 1.93 Billion 1.12 Billion 1.17 Billion
Cash and Cash Equivalents 428.43 Million 966.77 Million 2.11 Billion 1.5 Billion 835.08 Million 370.82 Million
Short Term Investments 1.24 Billion 1.02 Billion - 435.92 Million 289.66 Million 803.08 Million
Net Receivables 439.7 Million 259.69 Million 171.63 Million 138.58 Million 93.93 Million 49.04 Million
Inventory 322.85 Million 203.96 Million 186.21 Million 231.96 Million 171.37 Million 125.44 Million
Other Current Assets 140.51 Million 7.72 Million 6.14 Million 4.06 Million 5.24 Million 77.78 Million
Total Non-Current Assets 685.24 Million 570.5 Million 543.87 Million 499.52 Million 353.9 Million 215.89 Million
Net PPE 357.1 Million 244.99 Million 236.68 Million 282.19 Million 167.55 Million 97.02 Million
Good Will And Intangible Assets 29.62 Million 7.57 Million 14.23 Million 13.62 Million 12.49 Million 11.57 Million
Good Will - - - - - -
Intangible Assets 29.62 Million 7.57 Million 14.23 Million 13.62 Million 12.49 Million 11.57 Million
Long-Term Investments 22.1 Million 31.32 Million 34.89 Million 38.79 Million 31.93 Million 107.29 Million
Tax Assets -1.00 - 114.77 Million 151.92 Million 130.12 Million -107.29 Million
Other Non Current Assets 276.41 Million 286.61 Million 143.28 Million 12.98 Million 11.79 Million 107.29 Million
Other Assets 1.00 - - - - -
Total Liabilities 2.4 Billion 2.74 Billion 2.21 Billion 2.22 Billion 1 Billion 609.79 Million
Total Current Liabilities 653.65 Million 619.6 Million 452.73 Million 416.02 Million 264.76 Million 173.69 Million
Account Payables 164.91 Million 95.87 Million 76.74 Million 111.09 Million 68.09 Million 33.82 Million
Tax Payables 13.76 Million 12.52 Million 216 Thousand - - 301 Thousand
Short Term Debt 123.32 Million 15.48 Million 271.69 Million 193.55 Million 7.84 Million 134.09 Million
Deferred Revenue 50.41 Million 89.24 Million 89.24 Million 89.24 Million -7.84 Million 3.3 Million
Other Current Liabilities 314.99 Million 418.99 Million 15.05 Million 22.13 Million 196.67 Million 2.46 Million
Total Non Current Liabilities 1.75 Billion 2.12 Billion 1.76 Billion 1.8 Billion 739.86 Million 436.1 Million
Long-Term Debt 1.13 Billion 1.6 Billion 1.13 Billion 1.07 Billion 729.62 Million 420.55 Million
Deferred Revenue Non Current 437 Million 485 Million 574.24 Million 663.48 Million - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 41.1 Million 36.94 Million 54.6 Million 70.58 Million 10.24 Million 15.55 Million
Other Liabilities - - - - - -
Total Equity 859.33 Million 384.95 Million 928 Million 761.75 Million 818.18 Million 1.03 Billion
Stock Holders Equity 859.33 Million 384.95 Million 928 Million 761.75 Million 818.18 Million 1.03 Billion
Common Stock 9000.00 9000.00 9000.00 8000.00 8000.00 7000.00
Retained Earnings -4.44 Billion -3.91 Billion -3.2 Billion -2.84 Billion -2.29 Billion -1.57 Billion
Accumulated other comprehensive income 918 Thousand -1.66 Million -20 Thousand 3000.00 50 Thousand -99 Thousand
Common Stock Equity 859.33 Million 384.95 Million 928 Million 761.75 Million 818.18 Million 1.03 Billion
Capital Lease Obligation 140.96 Million 73.06 Million 41.51 Million 80.36 Million 47.72 Million -
Total Investments 1.26 Billion 1.05 Billion 34.89 Million 474.72 Million 321.6 Million 803.08 Million
Total Debt 1.39 Billion 1.61 Billion 1.13 Billion 1.07 Billion 729.62 Million 420.55 Million
Net Debt 968.37 Million 650.58 Million -977.48 Million -429.78 Million -105.46 Million 49.72 Million

Balance Sheet Charts